www.usatoday.com

www.usatoday.com
Share

www.usatoday.com

 •  October 16

Ensuring patient access to medicines that are revolutionizing how we fight disease is critically important. Equally so is understanding when additional safeguards are required to ensure a medicine’s benefits outweigh its risks. In such cases, the Food and Drug Administration may require the biopharmaceutical company that manufactures the medicine...

www.usatoday.com

 •  September 27

NorthJersey.com Pharmaceutical companies around the country have begun developing a range of non-addictive treatments in response to the country's deadly heroin and opiate crisis, but executives told a presidential panel that they face financial, regulatory and insurance obstacles that could delay meaningful progress toward curbing the abuse. In a...

www.usatoday.com

 •  September 27

“The cost of medicine in this country is outrageous,” President Trump said at a rally in Louisville, Ky., two months after his inauguration. He went on about how identical pills have vastly lower price tags in Europe. “You know why?” the president asked, before spreading his hands wide. “Campaign contributions, who knows. But somebody is getting...

www.usatoday.com

 •  September 26

Newslook The U.S. Food and Drug Administration is warning of possible "critical shortages" of key pharmaceuticals after Hurricane Maria brought Puerto Rico's drug manufacturing industry to a standstill. The FDA said late Monday that it is taking active measures to help redirect production and preserve existing treatments to avoid a ballooning...

www.usatoday.com

 •  September 19

ALBANY, N.Y. — Attorneys general across the country are demanding information from pharmaceutical companies in an ongoing investigation into prescription drug abuse. A bipartisan coalition of 41 attorneys general said Tuesday they have jointly filed subpoenas to major opioid distributors and manufacturers as they investigate how prescription drugs...

www.usatoday.com

 •  September 15

Pharmaceutical giant Bayer won swift U.S. regulatory approval to sell a drug that could help treat up to one in five lymphoma patients. The Food and Drug Administration has authorized the German drug maker to begin selling Aliqopa, which will treat adult patients who have relapsed after at least two previous therapies for follicular B-cell...

www.usatoday.com

 •  August 22

A new leukemia drug being hailed by doctors as a breakthrough could prove among the most expensive therapies ever on the market: For a single treatment, the price is expected to reach hundreds of thousands of dollars. “It is a revolutionary treatment,” said Dr. Prakash Satwani, a pediatric hematologist at NewYork-Presbyterian/Columbia University...

www.usatoday.com

 •  August 15

A day after President Trump lashed out at the black CEO of drug maker Merck on Twitter, his new Food and Drug Administration commissioner said brand name drug companies are "gaming the system" to block generic competition and vowed to do something about it. Physician and FDA chief Scott Gottlieb declined to comment on Trump's tweet urging Merck's...

www.usatoday.com

 •  June 14

KNOXVILLE, Tenn. — In an unprecedented move, three Tennessee prosecutors are taking aim at drugmakers who supplied the opiates that addicted millions, using the state’s long-ridiculed and rarely used “crack tax” law. The district attorneys general for three east Tennessee judicial districts collectively representing nine counties filed a lawsuit...

www.usatoday.com

 •  June 11

The Clarion-Ledger For two decades, drugmakers have largely dodged the blame for selling drugs that have played a key role in overdose-related deaths of more than twice the number of Americans than were killed in World War I, the Korean War and the Vietnam War combined. But a growing tide of lawsuits could succeed where many others have failed —...